CELL TRANSPLANTATION

Scope & Guideline

Exploring the future of cell and tissue therapies.

Introduction

Delve into the academic richness of CELL TRANSPLANTATION with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0963-6897
PublisherSAGE PUBLICATIONS INC
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 1992 to 2024
AbbreviationCELL TRANSPLANT / Cell Transplant.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2455 TELLER RD, THOUSAND OAKS, CA 91320

Aims and Scopes

The journal 'CELL TRANSPLANTATION' focuses on the advancements in stem cell therapy and transplantation, exploring innovative strategies and applications across various medical fields. It aims to bridge the gap between basic research and clinical applications, facilitating the translation of scientific discoveries into therapeutic interventions.
  1. Stem Cell Therapy and Regenerative Medicine:
    The journal emphasizes the role of stem cells in regenerative medicine, including their potential applications in treating a variety of conditions such as spinal cord injuries, neurodegenerative diseases, and organ failures.
  2. Transplantation Techniques and Innovations:
    Research on novel transplantation techniques and methodologies, including xenotransplantation and the use of bioengineered scaffolds, is a core focus, aiming to improve graft survival and functionality.
  3. Cellular Mechanisms and Molecular Pathways:
    Studies investigating the underlying cellular and molecular mechanisms of stem cell therapy, including the interaction of stem cells with their microenvironment and immune modulation, are prominently featured.
  4. Clinical Applications and Case Studies:
    The journal includes clinical studies and case reports that provide insights into the real-world applications and outcomes of stem cell transplantation, enhancing understanding of efficacy and safety.
  5. Technological Advancements in Cell Therapy:
    Research on innovative technologies, such as CRISPR gene editing and 3D bioprinting, aimed at enhancing the efficacy and precision of cell therapies, is a key area of interest.
Recent publications in 'CELL TRANSPLANTATION' indicate a dynamic evolution of research themes, with several emerging areas gaining traction. These trends highlight the journal's commitment to addressing contemporary challenges in the field of cell transplantation and regenerative medicine.
  1. Neuroregenerative Therapies:
    A significant increase in research focusing on neuroregenerative therapies, particularly for conditions like Alzheimer's disease and spinal cord injuries, reflects the growing interest in using stem cells to repair nervous system damage.
  2. Extracellular Vesicles and Exosome Therapy:
    Emerging studies on the therapeutic potential of extracellular vesicles and exosomes derived from stem cells underscore their role in mediating regenerative effects and immune modulation.
  3. Personalized Medicine and Patient-Specific Therapies:
    There is a notable trend towards personalized medicine, with research increasingly focusing on tailoring stem cell therapies to individual patient profiles for optimized outcomes.
  4. Immunomodulatory Properties of Stem Cells:
    Research on the immunomodulatory effects of stem cells is gaining importance, as understanding these mechanisms is crucial for improving transplant acceptance and reducing rejection.
  5. Integration of Advanced Technologies:
    The incorporation of advanced technologies such as machine learning, AI, and CRISPR gene editing into stem cell research is on the rise, offering new avenues for enhancing therapeutic efficacy.

Declining or Waning

While 'CELL TRANSPLANTATION' covers a broad spectrum of topics, certain themes have seen a decline in prominence in recent years. This shift may reflect changing research priorities or advancements in technology and methodologies.
  1. Traditional Organ Transplantation Methods:
    Research focusing on conventional organ transplantation techniques has decreased, possibly due to the increasing interest in stem cell therapies and bioengineering as alternative solutions.
  2. Less Emphasis on Non-stem Cell Therapies:
    There appears to be a waning interest in non-stem cell-based therapeutic approaches, as the field gravitates towards exploring the unique properties and advantages of stem cells.
  3. Limited Focus on Single-Mode Therapies:
    The journal has moved away from studies that advocate for single-mode therapies, reflecting a trend towards combination therapies that integrate various approaches for enhanced efficacy.
  4. Decreased Publications on Invasive Techniques:
    There is a noticeable decline in studies related to invasive transplantation techniques, as more researchers explore less invasive and more patient-friendly options.

Similar Journals

MOLECULAR MEDICINE

Catalyzing Collaboration in Molecular Research
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

Vestnik Transplantologii i Iskusstvennyh Organov

Transforming the landscape of organ transplantation research.
Publisher: FEDERAL RESEARCH CENTER TRANSPLANTOLOGY & ARTIFICIAL ORGANS V I SHUMAKOVISSN: 1995-1191Frequency: 4 issues/year

Vestnik Transplantologii i Iskusstvennyh Organov, published by the Federal Research Center Transplantology & Artificial Organs V I Shumakov, is an esteemed open access journal that has been disseminating critical research in the fields of transplantation and immunology since 2009. With an ISSN of 1995-1191 and E-ISSN 2412-6160, this journal serves as a vital resource for academics and practitioners alike, offering insights into current trends, innovations, and methodologies in organ transplantation. The journal is indexed in prominent databases, holding a Q4 category in Immunology and Allergy and a Q3 in Transplantation as of 2023, ranking 42nd out of 54 in the field of Medicine - Transplantation, and 208th out of 233 in Medicine - Immunology and Allergy. Through its commitment to open access publishing and its strategic focus on advancing the science of transplantology, Vestnik Transplantologii i Iskusstvennyh Organov contributes significantly to the global body of knowledge, promoting collaboration and engagement among researchers, healthcare professionals, and students from around the world.

Transplant Immunology

Unveiling the Complexities of Immunological Mechanisms in Transplantation.
Publisher: ELSEVIERISSN: 0966-3274Frequency: 6 issues/year

Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.

Egyptian Journal of Haematology

Advancing Hematology: Insights from Egypt and Beyond
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1110-1067Frequency: 4 issues/year

The Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.

Stem Cells International

Empowering Knowledge in Regenerative Biology
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Stem Cell Research & Therapy

Catalyzing Discoveries in Molecular Medicine
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

Regenerative Medicine

Pioneering Discoveries in Biomedical Regeneration
Publisher: TAYLOR & FRANCIS LTDISSN: 1746-0751Frequency: 12 issues/year

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

Tissue Engineering and Regenerative Medicine

Shaping Tomorrow’s Medical Breakthroughs Today
Publisher: KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOCISSN: 1738-2696Frequency: 6 issues/year

Tissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.

TRANSPLANTATION

Empowering Professionals with Cutting-edge Transplant Research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0041-1337Frequency: 12 issues/year

TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.

STEM CELLS

Innovating methodologies for transformative discoveries.
Publisher: OXFORD UNIV PRESSISSN: 1066-5099Frequency: 12 issues/year

STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.